These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 10985336)
1. Dendritic cells, exposed to primary, mixed phenotype HIV-1 isolates preferentially, but not exclusively, replicate CCR5-using clones. Vanham G; Davis D; Willems B; Penne L; Kestens L; Janssens W; van der Groen G AIDS; 2000 Aug; 14(12):1874-6. PubMed ID: 10985336 [No Abstract] [Full Text] [Related]
2. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones. Ariën KK; Gali Y; El-Abdellati A; Heyndrickx L; Janssens W; Vanham G Virology; 2006 Mar; 347(1):65-74. PubMed ID: 16386774 [TBL] [Abstract][Full Text] [Related]
3. The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells. Vanham G; van Tendeloo V; Willems B; Penne L; Kestens L; Beirnaert E; Fransen K; Heyndrickx L; Zhong P; Davis D; Berneman Z; van Der Groen G; Van Bockstaele D J Med Virol; 2000 Mar; 60(3):300-12. PubMed ID: 10630963 [TBL] [Abstract][Full Text] [Related]
4. Analysis of HIV-1-X4 fusion with immature dendritic cells identifies a specific restriction that is independent of CXCR4 levels. Pion M; Arrighi JF; Jiang J; Lundquist CA; Hartley O; Aiken C; Piguet V J Invest Dermatol; 2007 Feb; 127(2):319-23. PubMed ID: 16917492 [TBL] [Abstract][Full Text] [Related]
5. Partial inactivation of CCR5- and CXCR4- tropic HIV-1 by human urine. Auvert B; Jenabian MA; Saidi H; Lissouba P; Bélec L Arch Virol; 2011 Dec; 156(12):2181-6. PubMed ID: 21947506 [TBL] [Abstract][Full Text] [Related]
6. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Xiao L; Owen SM; Goldman I; Lal AA; deJong JJ; Goudsmit J; Lal RB Virology; 1998 Jan; 240(1):83-92. PubMed ID: 9448692 [TBL] [Abstract][Full Text] [Related]
7. Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient? Lathey JL; Brambilla D; Goodenow MM; Nokta M; Rasheed S; Siwak EB; Bremer JW; Huang DD; Yi Y; Reichelderfer PS; Collman RG J Leukoc Biol; 2000 Sep; 68(3):324-30. PubMed ID: 10985247 [TBL] [Abstract][Full Text] [Related]
8. Coreceptor usage by HIV-1 and HIV-2 primary isolates: the relevance of CCR8 chemokine receptor as an alternative coreceptor. Calado M; Matoso P; Santos-Costa Q; Espirito-Santo M; Machado J; Rosado L; Antunes F; Mansinho K; Lopes MM; Maltez F; Santos-Ferreira MO; Azevedo-Pereira JM Virology; 2010 Dec; 408(2):174-82. PubMed ID: 20947116 [TBL] [Abstract][Full Text] [Related]
9. An overview of the determinants of CCR5 and CXCR4 co-receptor function. Dragic T J Gen Virol; 2001 Aug; 82(Pt 8):1807-1814. PubMed ID: 11457985 [No Abstract] [Full Text] [Related]
10. The plasma membrane as a combat zone in the HIV battlefield. Doms RW; Trono D Genes Dev; 2000 Nov; 14(21):2677-88. PubMed ID: 11069884 [No Abstract] [Full Text] [Related]
11. Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism. Papkalla A; Münch J; Otto C; Kirchhoff F J Virol; 2002 Aug; 76(16):8455-9. PubMed ID: 12134048 [TBL] [Abstract][Full Text] [Related]
12. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines. Ito Y; Grivel JC; Chen S; Kiselyeva Y; Reichelderfer P; Margolis L J Infect Dis; 2004 Feb; 189(3):506-14. PubMed ID: 14745709 [TBL] [Abstract][Full Text] [Related]
13. HIV type 1 chemokine receptor usage in mother-to-child transmission. Salvatori F; Scarlatti G AIDS Res Hum Retroviruses; 2001 Jul; 17(10):925-35. PubMed ID: 11461678 [TBL] [Abstract][Full Text] [Related]
15. Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype. Karlsson I; Antonsson L; Shi Y; Oberg M; Karlsson A; Albert J; Olde B; Owman C; Jansson M; Fenyö EM J Virol; 2004 Nov; 78(21):11807-15. PubMed ID: 15479822 [TBL] [Abstract][Full Text] [Related]
16. Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection. Schmitt N; Nugeyre MT; Scott-Algara D; Cumont MC; Barré-Sinoussi F; Pancino G; Israël N AIDS; 2006 Feb; 20(4):533-42. PubMed ID: 16470117 [TBL] [Abstract][Full Text] [Related]
17. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Grivel JC; Ito Y; Fagà G; Santoro F; Shaheen F; Malnati MS; Fitzgerald W; Lusso P; Margolis L Nat Med; 2001 Nov; 7(11):1232-5. PubMed ID: 11689888 [TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus fusion to dendritic cells declines as cells mature. Cavrois M; Neidleman J; Kreisberg JF; Fenard D; Callebaut C; Greene WC J Virol; 2006 Feb; 80(4):1992-9. PubMed ID: 16439555 [TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Whitcomb JM; Huang W; Fransen S; Limoli K; Toma J; Wrin T; Chappey C; Kiss LD; Paxinos EE; Petropoulos CJ Antimicrob Agents Chemother; 2007 Feb; 51(2):566-75. PubMed ID: 17116663 [TBL] [Abstract][Full Text] [Related]
20. Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4(+) T cells. Vicenzi E; Panina-Bodignon P; Vallanti G; Di Lucia P; Poli G J Leukoc Biol; 2002 Nov; 72(5):913-20. PubMed ID: 12429712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]